InvestorsHub Logo
Followers 2
Posts 483
Boards Moderated 0
Alias Born 04/03/2017

Re: None

Wednesday, 08/09/2017 2:44:44 PM

Wednesday, August 09, 2017 2:44:44 PM

Post# of 6315
NB2111 patent concerns with GW being low energy

It would appear GW is being very Rude about protecting Epidiolex -->

https://hoban.law/blog/2017/2017-02/gw-pharmaceuticals-shot-across-bow-americas-hemp-and-cbd-industries

Thoughts on how this could effect NB2?

Also, did anyone see how GW has delayed completed their NDA for Epidiolex because of construction at a new extraction facility? If only there was a quicker and cheaper way To manufacture....

https://seekingalpha.com/article/4096071-gw-pharmaceuticals-gwph-ceo-justin-gover-q3-2017-results-earnings-call-transcript?part=single

Also, no mention of Sativex during the call. Swing and a Miss